Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells

Cell Reports

Volumn 14, Issue 7, 2016, Pages 1774-1786

  Tesone, Amelia J ^a   Rutkowski, Melanie R ^a   Brencicova, Eva ^a   Svoronos, Nikolaos ^a   Perales Puchalt, Alfredo ^a   Stephen, Tom L ^a   Allegrezza, Michael J ^a   Payne, Kyle K ^a   Nguyen, Jenny M ^a   Wickramasinghe, Jayamanna ^a   Tchou, Julia ^b   Borowsky, Mark E ^c   Rabinovich, Gabriel A ^d   Kossenkov, Andrew V ^a   Conejo Garcia, Jose R ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HELEN F GRAHAM CANCER CENTER   (United States)

^d INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTCH1 RECEPTOR; PROTEIN H2 AB1; PROTEIN SATB1; PROTEIN ZBTB46; TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG; HISTONE; HISTONE H2B TYPE 1-A; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; INTERLEUKIN-6, MOUSE; MATRIX ATTACHMENT REGION BINDING PROTEIN; NOTCH1 PROTEIN, MOUSE; PROTEIN BINDING; RBPJ PROTEIN, MOUSE; SATB1 PROTEIN, MOUSE; SMALL INTERFERING RNA; ZBTB46 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENIC ACTIVITY; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATORY CELL; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OVARY TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STEADY STATE; TRANSCRIPTION INITIATION; TUMOR IMMUNITY; TUMOR PROMOTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DENDRITIC CELLS; FEMALE; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTONES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; INTERLEUKIN-6; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84959123285     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.01.056     Document Type: Article

References (33)

1. Alvarez J.D., Yasui D.H., Niida H., Joh T., Loh D.Y., Kohwi-Shigematsu T. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev. 2000, 14:521-535.
2. Borghesi L. Hematopoiesis in steady-state versus stress: self-renewal, lineage fate choice, and the conversion of danger signals into cytokine signals in hematopoietic stem cells. J. Immunol. 2014, 193:2053-2058.
3. Cai S., Lee C.C., Kohwi-Shigematsu T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 2006, 38:1278-1288.
4. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., Holtz D.O., Jenkins A., Na H., Zhang L., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 2004, 10:950-958.
5. Cubillos-Ruiz J.R., Engle X., Scarlett U.K., Martinez D., Barber A., Elgueta R., Wang L., Nesbeth Y., Durant Y., Gewirtz A.T., et al. Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J. Clin. Invest. 2009, 119:2231-2244.
6. Cubillos-Ruiz J.R., Baird J.R., Tesone A.J., Rutkowski M.R., Scarlett U.K., Camposeco-Jacobs A.L., Anadon-Arnillas J., Harwood N.M., Korc M., Fiering S.N., et al. Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. Cancer Res. 2012, 72:1683-1693.
7. Cubillos-Ruiz J.R., Silberman P.C., Rutkowski M.R., Chopra S., Perales-Puchalt A., Song M., Zhang S., Bettigole S.E., Gupta D., Holcomb K., et al. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis. Cell 2015, 161:1527-1538.
8. Dalotto-Moreno T., Croci D.O., Cerliani J.P., Martinez-Allo V.C., Dergan-Dylon S., Méndez-Huergo S.P., Stupirski J.C., Mazal D., Osinaga E., Toscano M.A., et al. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res. 2013, 73:1107-1117.
9. Helft J., Böttcher J., Chakravarty P., Zelenay S., Huotari J., Schraml B.U., Goubau D., Reis e Sousa C. GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity 2015, 42:1197-1211.
10. Huarte E., Cubillos-Ruiz J.R., Nesbeth Y.C., Scarlett U.K., Martinez D.G., Buckanovich R.J., Benencia F., Stan R.V., Keler T., Sarobe P., et al. Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Res. 2008, 68:7684-7691.
11. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 10:981-991.
12. Joffre O., Nolte M.A., Spörri R., Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 2009, 227:234-247.
13. Lee B.K., Iyer V.R. Genome-wide studies of CCCTC-binding factor (CTCF) and cohesin provide insight into chromatin structure and regulation. J. Biol. Chem. 2012, 287:30906-30913.
14. Lochamy J., Rogers E.M., Boss J.M. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes. Mol. Immunol. 2007, 44:837-847.
15. Meredith M.M., Liu K., Darrasse-Jeze G., Kamphorst A.O., Schreiber H.A., Guermonprez P., Idoyaga J., Cheong C., Yao K.H., Niec R.E., Nussenzweig M.C. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 2012, 209:1153-1165.
16. Murtaugh L.C., Stanger B.Z., Kwan K.M., Melton D.A. Notch signaling controls multiple steps of pancreatic differentiation. Proc. Natl. Acad. Sci. USA 2003, 100:14920-14925.
17. Nakano N., Nishiyama C., Yagita H., Koyanagi A., Akiba H., Chiba S., Ogawa H., Okumura K. Notch signaling confers antigen-presenting cell functions on mast cells. J. Allergy Clin. Immunol. 2009, 123:74-81.e1.
18. Nesbeth Y., Scarlett U., Cubillos-Ruiz J., Martinez D., Engle X., Turk M.J., Conejo-Garcia J.R. CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Res. 2009, 69:6331-6338.
19. Notani D., Gottimukkala K.P., Jayani R.S., Limaye A.S., Damle M.V., Mehta S., Purbey P.K., Joseph J., Galande S. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010, 8:e1000296.
20. Pavan Kumar P., Purbey P.K., Sinha C.K., Notani D., Limaye A., Jayani R.S., Galande S. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol. Cell 2006, 22:231-243.
21. Roby K.F., Taylor C.C., Sweetwood J.P., Cheng Y., Pace J.L., Tawfik O., Persons D.L., Smith P.G., Terranova P.F. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 2000, 21:585-591.
22. Rubinstein N., Alvarez M., Zwirner N.W., Toscano M.A., Ilarregui J.M., Bravo A., Mordoh J., Fainboim L., Podhajcer O.L., Rabinovich G.A. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004, 5:241-251.
23. Rutkowski M.R., Stephen T.L., Svoronos N., Allegrezza M.J., Tesone A.J., Perales-Puchalt A., Brencicova E., Escovar-Fadul X., Nguyen J.M., Cadungog M.G., et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell 2015, 27:27-40.
24. Satpathy A.T., Kc W., Albring J.C., Edelson B.T., Kretzer N.M., Bhattacharya D., Murphy T.L., Murphy K.M. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 2012, 209:1135-1152.
25. Scarlett U.K., Cubillos-Ruiz J.R., Nesbeth Y.C., Martinez D.G., Engle X., Gewirtz A.T., Ahonen C.L., Conejo-Garcia J.R. In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Cancer Res. 2009, 69:7329-7337.
26. Scarlett U.K., Rutkowski M.R., Rauwerdink A.M., Fields J., Escovar-Fadul X., Baird J., Cubillos-Ruiz J.R., Jacobs A.C., Gonzalez J.L., Weaver J., et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J. Exp. Med. 2012, 209:495-506.
27. Schraml B.U., van Blijswijk J., Zelenay S., Whitney P.G., Filby A., Acton S.E., Rogers N.C., Moncaut N., Carvajal J.J., Reis e Sousa C. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 2013, 154:843-858.
28. Segura E., Amigorena S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 2013, 34:440-445.
29. Segura E., Touzot M., Bohineust A., Cappuccio A., Chiocchia G., Hosmalin A., Dalod M., Soumelis V., Amigorena S. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013, 38:336-348.
30. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., Zwirner N.W., Poirier F., Riley E.M., Baum L.G., Rabinovich G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007, 8:825-834.
31. Vega-Ramos J., Roquilly A., Zhan Y., Young L.J., Mintern J.D., Villadangos J.A. Inflammation conditions mature dendritic cells to retain the capacity to present new antigens but with altered cytokine secretion function. J. Immunol. 2014, 193:3851-3859.
32. Yasui D., Miyano M., Cai S., Varga-Weisz P., Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 2002, 419:641-645.
33. Zhou J., Cheng P., Youn J.I., Cotter M.J., Gabrilovich D.I. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 2009, 30:845-859.